HETEROLOGOUS EXPRESSION FOR IDENTIFYING METABOLIC PATHWAYS
3
brief heating. Gas chromatography-mass spectrometry
(GC-MS) analysis was performed on a model 7820A gas
chromatograph (Agilent Technologies, Wilmington, DE)
equipped with a model MSD 5977E mass spectrometer
(Agilent Technologies). A fused-silica capillary Rtx-200
column (30 m length, 0.32 mm i.d.; Restex, Bellefonte,
PA) was used and helium was supplied through the
column as the carrier gas at 10 mL/min. The oven tem-
perature was programmed from 60 to 250°C at an
increase rate of 4°C/min. The injection port temperature
was maintained at 245°C. The GC column effluent was
introduced directly into the ion source via a transfer line
at 280°C. The ion source temperature was set at 230°C.
The split ratio for the injection and the electron impact
ionization voltage were set to 50:1 and 70 eV, respectively.
1.90 (1H, ddd, J = 12.7, 3.9, 3.9 Hz, H-4), 2.07 (1H, td,
J = 13.9, 2.7 Hz, H-2), 3.82 (1H, td, J = 3.7, 2.7 Hz, H-3),
4.98 (2H, m, H-10); 13C NMR (CDCl3, 125 MHz) δ
146.0 (C, C-8), 113.1 (CH2, C-10), 71.4 (C, C-1), 67.3
(CH, C-3), 53.9 (C, C-4), 46.1 (CH2, C-2), 38.1 (CH2,
C-6), 31.7 (CH3, C-7), 25.3 (CH2, C-5), 19.3 (CH3, C-9).
The assigned compound was confirmed by comparison
Preparation of esters with (R)-(–) - and (S)-(+)-2-
methoxy-2-phenyl-3,3,3-trifluoropropanoic acids
Esters of 1-methyl-4-(1-methylethenyl)-1,3-cyclohexa-
nediol (MMC) with (R)-(–)- and (S)-(+)-2-methoxy-2-
phenyl-3,3,3-trifluoropropanoic acids (MTPA esters)
were prepared by the method of Ohtani et al. [31],
respectively. MMC (0.023 mmol) was dissolved in
2.0 ml dichloromethane and stirred with (R)-(–)- or
(S)-(+)-α-methoxy-α-(trifluoromethyl)phenylacetyl
chloride (0.041 mmol), trimethylamine (0.090 mmol),
and 4-dimethylaminopyridine (0.004 mmol) at room
temperature for 30 min under N2. The reaction mixture
was concentrated in vacuo, and then (R)-(–)- or (S)-
(+)-MTPA esters of MMC was purified by silica gel
open-column chromatography.
Time courses of biotransformation and
autoxidation
One hundred and fifty microliters of precultured Tol 5
or Tol 5 (pGeoA) cells was inoculated into 15 mL BS
medium supplemented with 8 μL toluene in a 50-mL
conical centrifuge tube. When the OD660 of the culture
reached 1.0, 80 mM citral, geraniol, or nerol dissolved in
20 mM DMSO was added to the culture for their
biotransformation. During incubation at 28°C for
14 days with shaking at 115 rpm, 1 mL culture was
harvested every other day, saturated with NaCl, and
extracted with EtOAc, followed by evaporation of the
solvent. The crude extracts were analyzed by TLC, GC,
and GC-MS. To isolate a biotransformation product of
citral by Tol 5, the crude extract obtained from a culture
of the biotransformation for 14 days was subjected to
silica gel open-column chromatography (silica gel,
40–66 µm; Wako) with gradient elution (hexane/
EtOAc: 9:1 – 1:9). Relative abundances of the substrates
and their metabolites were determined on the basis of
GC peak area. Citral autoxidation was investigated at
the same condition in the absence of microbial cells.
The identities of the autoxidation products of citral
were confirmed by comparison of their mass spectra
to data reported in the literature [25–29], computa-
tional searches of a commercial mass spectral library
(NIST 14, which includes 276,248 EI spectra for 242,466
compounds), and of authentic samples.
Results
Tolerance of Acinetobacter sp. Tol 5 to citral
Since citral and some its biotransformation products
show antimicrobial activity [2], the tolerance of a host
strain to citral is an important factor for its biotrans-
formation. The tolerance of Tol 5 cells to citral was
investigated using the growth inhibition assay.
Maximum growth rates (μmax) at different concentra-
tions of citral (10–100 mM) and µmax0 (in the absence
of citral) were determined. The ratios of µmax and
µmax0 were plotted against different concentrations of
citral (Figure 2). The cell growth of Tol 5 was signifi-
cantly affected at 10 mM citral, distinctly impaired at
90 mM, and completely ceased at 100 mM. Since
6.6 μM – 29 mM citral was subjected to biotransfor-
mation in previous studies [11–17]. Tol 5 has sufficient
tolerance to be used for citral biotransformation.
Structural analysis of 1-methyl-4-(1-
methylethenyl)-1,3-cyclohexanediol as an
isolated biotransformation product
Capability of citral biotransformation in
Acinetobacter sp. Tol 5
From the metabolic versatility of Tol 5 [20,21], we
expected it would possess the capability for citral bio-
transformation. Biotransformation was investigated by
incubating Tol 5 cells at 28°C with 80 mM citral for
14 days. To distinguish biotransformation products
from autoxidation products, citral was also incubated in
the same condition except for the absence of Tol 5 cells.
The proportion of geranial and neral was 55:45 in the
Pale yellow oil: [α]D21.9 − 19.1° (CHCl3, c 0.70); EIMS,
m/z (rel. intensity) 170 [M]+ (1), 152 (13), 134 (19), 119
(21), 108 (55), 87 (40), 82 (31), 68 (100), 58 (27), 43 (47);
IR (KBr, νmax, cm−1) 3396; 1H NMR (CDCl3, 500 MHz)
δ 1.28 (3H, s, H-7), 1.41 (1H, dd, J = 11.6, 2.7 Hz, H-6),
1.43 (1H, m, H-5), 1.50 (1H, dd, J = 13.9, 2.7, Hz, H-2),
1.68 (1H, m, H-5), 1.75 (3H, s, H-9), 1.85 (1H, m, H-6),